Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Beena Salhan
Observed name:
B. Salhan
Institution:
University Hospitals Birmingham NHS Foundation Trust
Observed institutions:
University Hospitals Birmingham NHS Foundation Trust,
Good Hope Hospital,
University Hospitals of North Midlands NHS Trust,
Northampton General Hospital,
Heartlands Hospital,
Cannock Chase Hospital,
Solihull Hospital,
The Royal Wolverhampton NHS Trust
show all 8
OpenAlex ID:
A5074248807
COVID‐19 in bone marrow transplant recipients: reflecting on a single centre experience
2020
·
Alexandros Kanellopoulos
, Maria Z. Ahmed
, et al.
·
British Journal of Haematology
·
50
PDF
Diagnostic uncertainty presented barriers to the timely management of acute thrombotic thrombocytopenic purpura in the United Kingdom between 2014 and 2019
2022
·
Tom P. Bull
, Rory McCulloch
, et al.
·
Journal of Thrombosis and Haemostasis
·
26
PDF
SARS-CoV-2 vaccine responses following CD20-depletion treatment in patients with haematological and rheumatological disease: a West Midlands Research Consortium study
2021
·
Adrian M Shields
, Srinivasan Venkatachalam
, et al.
·
Clinical & Experimental Immunology
·
24
PDF
A Rare Presentation of Imperforate Hymen: A Case Report
2013
·
Beena Salhan
, Olufunmilayo Theresa Omisore
, et al.
·
Case Reports in Urology
·
20
PDF
Efficacy of Isatuximab With Pomalidomide and Dexamethasone in Relapsed Myeloma: Results of a UK-Wide Real-World Dataset
2022
·
Faouzi Djebbari
, Alexandros Rampotas
, et al.
·
HemaSphere
·
14
Infections in relapsed myeloma patients treated with isatuximab plus pomalidomide and dexamethasone during the COVID-19 pandemic: Initial results of a UK-wide real-world study
2022
·
Faouzi Djebbari
, Alexandros Rampotas
, et al.
·
Hematology
·
6
PDF
DPACE‐based chemotherapy in the era of myeloma novel agents: A UK multicentre study
2020
·
Faouzi Djebbari
, Kanchana De Abrew
, et al.
·
European Journal Of Haematology
·
6
Vaccine Efficacy after Rituximab Exposure: First Interim Analysis of Virtue Project on Behalf of West Midlands Research Consortium, UK
2021
·
Adrian M Shields
, Srinivasan Venkatachalam
, et al.
·
Blood
·
3
PDF
A HaemSTAR-led, UK-wide 'flash-mob’ audit of intravenous immunoglobulin use in immune thrombocytopenia
2019
·
Phillip Nicolson
, Rita Perry
, et al.
·
Clinical Medicine
·
3
PDF
Belantamab Mafodotin Monotherapy for Multiply‐Relapsed Myeloma: A Retrospective Study From the United Kingdom and the Republic of Ireland
2025
·
Edmund C. R. Watson
, Faouzi Djebbari
, et al.
·
eJHaem
·
2
PDF
Isatuximab with Pomalidomide and Dexamethasone Provides Comparable Efficacy Outcomes in Frail Routine Care Myeloma Patients in a UK-Wide Cohort
2022
·
Alexandros Rampotas
, Alexandros Rampotas
, et al.
·
Blood
·
1
Efficacy Outcomes of Isatuximab with Pomalidomide and Dexamethasone Are Comparable to (ICARIA-MM) Trial Data: Initial Results of a UK-Wide Real-World Study of Relapsed Myeloma Patients
2021
·
Faouzi Djebbari
, Grant Vallance
, et al.
·
Blood
·
1
213. the Impact of Treating to Target in Patients With Rheumatoid Arthritis: Real-world Evidence From a Single Centre
2017
·
Ahmed Yousif
, Martin Konar
, et al.
·
Rheumatology
·
1
P-322 Real world outcomes of belantamab mafodotin from the UK and Ireland: updated results
2023
·
Edmund Watson
, Faouzi Djebbari
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Frailty subgroup analysis of isatuximab with pomalidomide and dexamethasone in a UK ‐wide real‐world cohort of relapsed myeloma patients
2023
·
Faouzi Djebbari
, Alexandros Rampotas
, et al.
·
British Journal of Haematology
PDF
Management of Allogeneic Stem Cell Transplantation for High-Risk AML following SARS-CoV-2 Associated Pancytopenia with Marked Bone Marrow Biopsy Alterations
2021
·
Maria Kaparou
, Zbigniew Rudzki
, et al.
·
Case Reports in Hematology
PDF
Consolidation following DPACE therapy improves outcomes in relapsed/refractory myeloma patients in the era of novel agents
2019
·
Faouzi Djebbari
, Kanchana De abrew
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Pf629 Consolidation Following Infusional Dpace Improves Outcomes in Novel Agent Relapsed/refractory Myeloma Patients
2019
·
F. Djebbari
, K. Deabrew
, et al.
·
HemaSphere
Show more works
View as search
Works count:
18
Citation count:
157
H-index:
6
I10-index:
5
Year
Topic
Type